Skip to content
Esta página está disponible en españolCambiar →

Great investors · Andreas Halvorsen · Q3 2025

What Andreas Halvorsen bought and sold in Q3 2025

Viking Global 13F portfolio as of Sep 30, 2025: 78 positions worth $38.5 bn. Largest: PNC, JPM, SCHW, COF. Filed with the SEC on Nov 14, 2025.

The 13F is filed by Viking Global, not by Andreas Halvorsen personally: these are the whole firm's positions. A “position” is a distinct security in the filing (by CUSIP); share classes of the same company are shown added together.

Buys in Q3 2025

Sells in Q3 2025

43 companies with material moves, out of 86 positions with a change. Only moves of 0.5 points of the portfolio or more are listed, measured as “traded weight” (what was bought or sold, excluding price effects). Smaller changes exist and are not listed: a position may have gone up or down without appearing above.

The full 13F, line by line

Viking Global's Q3 2025 13F lists 78 lines of US-listed securities worth $38.5 bn; the largest is PNC at 4.15% of the portfolio. It was accepted by the SEC on Nov 14, 2025 at 4:42 PM ET.

Against the previous quarter, it opened 15 positions (MSFT, NFLX, DKNG and AON and 11 more), closed 20 (USB, AMZN, FLUT and AMT and 16 more), added to 30 (PNC, JCI, UBS and META and 26 more) and trimmed 22 (BAC, ROST, HCA and BMRN and 18 more). 11 lines show the same number of shares.

#CompanySharesValueWeightChange in shares
1PNC Financial Services Group PNC8.0 M$1.6 bn4.15%+235%
2JPMorgan Chase JPM5.1 M$1.6 bn4.14%+25%
3Charles Schwab SCHW16.6 M$1.6 bn4.11%+5.1%
4Capital One Financial COF7.4 M$1.6 bn4.08%+30%
5Microsoft MSFT2.4 M$1.3 bn3.27%new
6Walt Disney DIS10.4 M$1.2 bn3.11%+79%
7Taiwan Semiconductor Manufacturing TSM3.9 M$1.1 bn2.86%−8.9%
8McDONALD’S MCD3.4 M$1.0 bn2.66%+8%
9Fortive FTV20.5 M$1.0 bn2.61%+29%
10Air Products and Chemicals APD3.7 M$1.0 bn2.60%+70%
11Sherwin-williams SHW2.9 M$998M2.59%+47%
12Visa V2.9 M$989M2.57%+79%
13BridgeBio Pharma BBIO16.0 M$830M2.16%−14%
14General Motors GM13.0 M$794M2.06%no change
15Carvana CVNA2.1 M$793M2.06%+95%
16T-mobile US TMUS3.3 M$781M2.03%+15%
17Johnson Controls International JCI6.8 M$747M1.94%+368%
18BlackRock BLK619,492$722M1.88%+218%
19Philip Morris International PM4.4 M$718M1.86%+28%
20Tesla TSLA1.6 M$716M1.86%+46%
21Meta Platforms META929,003$682M1.77%+250%
22Advanced Micro Devices AMD4.2 M$676M1.76%+119%
23Boeing BA3.0 M$650M1.69%+6.2%
24Nike NKE9.0 M$627M1.63%+29%
25Netflix NFLX500,812$600M1.56%new
26Bank of America BAC11.5 M$593M1.54%−63%
27HCA Healthcare HCA1.4 M$588M1.53%−26%
28CSX CSX15.9 M$566M1.47%−15%
29Draftkings DKNG15.0 M$561M1.46%new
30Cencora COR1.8 M$556M1.44%−15%
31Danaher DHR2.8 M$545M1.42%−5.4%
32Sea SE3.0 M$543M1.41%−14%
33UBS Group UBS13.1 M$535M1.39%+408%
34Primo Brands PRMB23.0 M$509M1.32%+18%
35Aon AON1.4 M$504M1.31%new
36TIC Solutions TIC34.4 M$457M1.19%no change
37BioMarin Pharmaceutical BMRN8.3 M$451M1.17%−32%
38Adaptive Biotechnologies ADPT30.0 M$449M1.17%no change
39Regal Rexnord RRX3.1 M$448M1.16%−8.9%
40Celestica CLS1.7 M$424M1.10%new
41APi Group APG12.3 M$423M1.10%−29%
42Saia SAIA1.4 M$414M1.08%+67%
43Camden Property Trust CPT3.8 M$411M1.07%+42%
44Mid-america Apartment Communities MAA2.6 M$370M0.96%new
45Roivant Sciences ROIV23.6 M$357M0.93%−31%
46KKR KKR2.7 M$352M0.91%new
47Ross Stores ROST2.0 M$308M0.80%−57%
48Chipotle Mexican Grill CMG6.6 M$260M0.68%+17%
49Boston Scientific BSX2.6 M$258M0.67%−13%
50Edwards Lifesciences EW3.1 M$239M0.62%new
51Ralliant RAL5.1 M$222M0.58%−4.2%
52Chewy CHWY5.5 M$222M0.58%new
53Amer Sports AS6.3 M$220M0.57%+63%
54Deutsche Bank Aktiengesellschaft DB6.1 M$215M0.56%new
55CBRE Group CBRE1.2 M$191M0.50%new
56NewAmsterdam Pharma NAMS6.5 M$184M0.48%−7.2%
57Intuit INTU264,136$180M0.47%new
58Deckers Outdoor DECK1.7 M$175M0.45%new
59First Solar FSLR767,996$169M0.44%−66%
60Masimo MASI1.1 M$158M0.41%+40%
61CoStar Group CSGP1.8 M$156M0.41%−43%
62AppLovin APP162,525$117M0.30%−56%
63RYAN Specialty Holdings RYAN1.9 M$109M0.28%+37%
64Integer Holdings ITGR1.0 M$106M0.27%−20%
65Sionna Therapeutics SION3.2 M$94.0M0.24%no change
66Pharvaris PHVS3.7 M$91.2M0.24%no change
67ORIC Pharmaceuticals ORIC6.6 M$78.9M0.20%no change
68Standard Biotools LAB58.7 M$76.2M0.20%no change
69Inhibrx Biosciences INBX1.8 M$60.2M0.16%no change
70Ginkgo Bioworks Holdings DNA3.6 M$52.2M0.14%no change
71Oruka Therapeutics ORKA2.7 M$51.3M0.13%new
72TEVA Pharmaceutical Industries TEVA2.5 M$51.1M0.13%−78%
73Trevi Therapeutics TRVI5.1 M$46.9M0.12%+232%
74Stubhub Holdings STUB2.0 M$34.4M0.09%new
75Maplebear CART832,857$30.6M0.08%−78%
76Pepgen PEPG3.5 M$16.1M0.04%+135%
77Establishment Labs Holdings ESTA343,465$14.1M0.04%no change
78Rallybio 4.2 M$2.1M0.01%no change

Positions it closed (20)

One row per line of the filing (by CUSIP): share classes of the same company are listed separately here. “Change in shares” compares the count with the previous quarter, split-adjusted; the value is the one reported in the 13F at quarter end, not today's price.

Original documents: Viking Global's 13F filings on EDGAR (SEC) ↗

Full 13F of Viking Global: sectors and history →

Follow Andreas Halvorsen and see their Q3 2026 13F once it is filed

Free. We email you (if you turn it on) and in Following you see what each manager you follow bought and sold.

Follow Andreas Halvorsen

Source: 13F filings with the SEC. A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions. Not investment advice.

Follow Andreas Halvorsen for free

When the next 13F is filed, we email you (if you turn it on) and it shows in your list. No credit card.

Follow Andreas Halvorsen